Surrogate endpoints in randomized cardiovascular clinical trials
Domanski M, Pocock S, Bernaud C, Borer J, Geller N, Revkin J, Zannad F. Surrogate endpoints in randomized cardiovascular clinical trials. Fundamental & Clinical Pharmacology 2010, 25: 411-413. PMID: 20698890, DOI: 10.1111/j.1472-8206.2010.00865.x.Peer-Reviewed Original ResearchConceptsSurrogate endpointsClinical trialsPhase III clinical trialsPhase III trialsCardiovascular clinical trialsIII trialsRandomized cardiovascular clinical trialsClinical endpointsTherapeutic pathwaysPhase IEndpointTrialsTreatment effectsCEI